Bethesda, Maryland 20892

  • Pancreatic Insufficiency (Exocrine and Endocrine)

Purpose:

This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (genotypes) of cystic fibrosis.


Study summary:

This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (genotypes) of cystic fibrosis.


Criteria:

- INCLUSION CRITERIA - Patients with known or suspected CF and family members of patients with CF. - >=4 years of age EXCLUSION CRITERIA -Concomitant medical, psychiatric or other problems which might complicate interpretation of studies of CF, or for which we are unable to provide adequate care.


NCT ID:

NCT00001223


Primary Contact:

Principal Investigator
Milica S Chernick, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Milica S Chernick, M.D.
Phone: (301) 496-3434
Email: milicac@bdg10.niddk.nih.gov


Backup Contact:

N/A


Location Contact:

Bethesda, Maryland 20892
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: December 07, 2022

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.